Exploring new molecular structures from unique enzyme transformations.
Enzyme Chemistry and Biological Function of RiPP-like Modifications.
['FUNDING_R01'] · VANDERBILT UNIVERSITY · NIH-11224193
This study is exploring special types of peptides made by our cells to understand how they are created and what they do, which could help us discover new treatments for various health conditions.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | VANDERBILT UNIVERSITY (nih funded) |
| Locations | 1 site (Nashville, UNITED STATES) |
| Trial ID | NIH-11224193 on ClinicalTrials.gov |
What this research studies
This research investigates the chemistry and biological functions of ribosomally synthesized and post-translationally modified peptides (RiPPs). By utilizing advanced genomic analysis tools like RODEO, the team aims to identify and characterize new molecular structures formed through unusual enzymatic transformations. The study focuses on understanding the biosynthetic routes and the diverse functions of these peptides, which could lead to new insights in molecular biology and potential therapeutic applications.
Who could benefit from this research
Good fit: Ideal candidates for this research would be individuals interested in the biochemical and therapeutic potential of novel peptide structures.
Not a fit: Patients with conditions unrelated to peptide biology or those not interested in experimental biochemical research may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of novel peptides with unique properties that may have therapeutic applications.
How similar studies have performed: While the exploration of RiPPs is a well-established field, the specific approach of utilizing AI-based genome mining tools for novel RiPP-like structures is relatively novel and untested.
Where this research is happening
Nashville, UNITED STATES
- VANDERBILT UNIVERSITY — Nashville, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MITCHELL, DOUGLAS ALAN — VANDERBILT UNIVERSITY
- Study coordinator: MITCHELL, DOUGLAS ALAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.